Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 1997

View Archived Issues

Positive preclinical results for Inflazyme's Apanol

Protein Sciences' influenza vaccine covered under U.S. patent

Vion antiinfective covered under U.S. patent

T Cell Sciences completes patient enrollment for reperfusion injury trial

FDA advisory committee review of EchoGen postponed

Lilly and Megabios enter gene-based therapeutics collaboration

Xenova and Warner-Lambert enter further drug discovery collaboration

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

AMBI reports positive results for Cardia Salt Alternative

HIV drug resistance test launched by Murex

MS&D prepares CCK-B/gastrin receptor antagonists

Cephems active against MRSA reported by Bristol-Myers Squibb

Ion channel-forming peptides from Magainin

Mallinckrodt describes new imaging agents

Merck & Co. discloses pneumococcal vaccines

Antimigraine agents from Janssen

Lilly describes agents for Alzheimer's disease

Antiallergic/antiasthmatic agents from Sumitomo Metal

Company Profile: AntiVirals

Astra shifts focus to newer thrombin inhibitor

BTI-322 preclinical and clinical data disclosed at transplant meeting

Anti-LFA-1 MAbs for transplantation

Leflunomide preclinical results presented at transplant congress

Agouron reports structure-based design of calcineurin inhibitors

New NSAID under development in Russia

Molecular structure of prostaglandins responsible for HSF1 activation elucidated

Cardioprotective effects of K-7259 in rat hearts

New i.v. formulation of amiodarone better tolerated in patients

Clinical electrophysiological and hemodynamic effects of BRL-32872A

Mechanism of antiarrhythmic effect of UK-14304